Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
46.38 EUR | +3.43% | +6.86% | -4.60% |
Apr. 24 | COVIVIO : Invest Securities remains Buy after sales release | CF |
Apr. 24 | Covivio: stable revenues in Q1 | CF |
Sales 2024 * | 1.08B 1.16B | Sales 2025 * | 1.09B 1.17B | Capitalization | 4.49B 4.83B |
---|---|---|---|---|---|
Net income 2024 * | 118M 127M | Net income 2025 * | 499M 536M | EV / Sales 2024 * | 10.2 x |
Net Debt 2024 * | 6.44B 6.92B | Net Debt 2025 * | 6.31B 6.79B | EV / Sales 2025 * | 9.91 x |
P/E ratio 2024 * |
45.3
x | P/E ratio 2025 * |
8.99
x | Employees | - |
Yield 2024 * |
7.6% | Yield 2025 * |
7.67% | Free-Float | 67.78% |
Latest transcript on Covivio
1 day | +2.85% | ||
1 week | +6.12% | ||
Current month | -3.31% | ||
1 month | +0.87% | ||
3 months | +1.10% | ||
6 months | +23.12% | ||
Current year | -5.26% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 58 | 01-09-30 | |
Paul Arkwright
DFI | Director of Finance/CFO | 38 | 13-12-31 |
Chief Tech/Sci/R&D Officer | 36 | 18-02-14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 70 | 11-01-30 | |
Olivier Piani
BRD | Director/Board Member | 70 | 19-04-16 |
Chief Executive Officer | 58 | 01-09-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.43% | 2 M€ | +7.72% | ||
0.31% | 208 M€ | -.--% | ||
0.30% | 285 M€ | -4.89% | ||
0.22% | 182 M€ | +6.98% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 46.38 | +3.43% | 19 408 |
24-04-25 | 44.84 | 0.00% | 196,077 |
24-04-24 | 44.84 | 0.00% | 186,972 |
24-04-23 | 44.84 | +0.99% | 162,237 |
24-04-22 | 44.4 | +2.16% | 161,528 |
Real-time Euronext Paris, April 26, 2024 at 04:53 am EDT
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-5.26% | 4.81B | |
-6.30% | 46.33B | |
-7.47% | 20.51B | |
-4.26% | 12.94B | |
+16.29% | 11.45B | |
-5.34% | 9.75B | |
-0.47% | 8.51B | |
-14.85% | 8.43B | |
+1.30% | 7.6B | |
-16.19% | 5.69B |
- Stock Market
- Equities
- COV Stock